A PSA of 127 indicated a high probability of prostate cancer, leading to immediate Lupron ADT therapy and radiation treatment. Initial diagnosis and treatment left the author feeling weak and ...
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have launched a clinical trial, called ANDROMEDA, to ...
Investigators evaluated the benefit of leuprorelin immediately after radical prostatectomy for prostate cancer in patients with undetectable PSA levels.
Data from a major U.S. clinical trial from the Alliance for Clinical Trials in Oncology has uncovered a genetic factor that ...
News-Medical.Net on MSN
Study tests combined targeted radiopharmaceuticals and precision radiation for recurrent prostate cancer
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether ...
The patients received Lutetium (177Lu) rhPSMA-10.1 Injections at both St Bartholomew's Hospital, London, and The James Cook University Hospital, Middlesbrough -- Lutetium (177Lu) rhPSMA-10.1 Injection ...
A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks, after a campaign by a patient and a charity. Abiraterone has been provided on the NHS ...
Former senator and ex-University of Florida president Ben Sasse announced on Tuesday, Dec. 23, he was diagnosed with stage 4 terminal cancer. "This is a tough note to write, but since a bunch of you ...
Mr. Sasse, a former senator from Nebraska, announced that he had received a diagnosis last week for Stage 4 pancreatic cancer. By Adeel Hassan Charles Homans and Stephanie Saul Ben Sasse, a Republican ...
Former Sen. Ben Sasse, R-Neb., announced Tuesday that he has been diagnosed with "metastasized, stage-four pancreatic cancer," writing in an X post that the diagnosis is "a death sentence." "Last week ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results